Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods
Nuzhat Ahmed, Elif Kadife, Ali Raza, Mary Short, Paul T Jubinsky, George Kannourakis
Cells | MDPI | Published : 2020
Epithelial ovarian cancer (EOC) constitutes 90% of ovarian cancers (OC) and is the eighth most common cause of cancer-related death in women. The cancer histologically and genetically is very complex having a high degree of tumour heterogeneity. The pathogenic variability in OC causes significant impediments in effectively treating patients, resulting in a dismal prognosis. Disease progression is predominantly influenced by the peritoneal tumour microenvironment rather than properties of the tumor and is the major contributor to prognosis. Standard treatment of OC patients consists of debulking surgery, followed by chemotherapy, which in most cases end in recurrent chemoresistant disease. Th..View full abstract
This work was supported by the John Turner Cancer Research Funds to Fiona Elsey Cancer Research Institute, Ballarat, Australia. N.A. is a recipient of the John Turner Professorial Fellowship; AR is a recipient of the John Turner Postgraduate Scholarship. This work was made possible through the Victorian State Government Operational Infrastructure Support to the Hudson Institute of Medical Research.